Cleveland Clinic Department of Rheumatic and Immunologic Disease
D

Cytokine Storm: Where Rheumatologists, Oncologists, and ID Meet

By Cleveland Clinic Department of Rheumatic and Immunologic Disease FEATURING David Fajgenbaum
By Cleveland Clinic Department of Rheumatic and Immunologic Disease FEATURING David Fajgenbaum
198 views
April 18, 2023
Comments 1
Login to view comments. Click here to Login

Related Videos

15:26

The Facts About COVID-19 Delta Breakthrough Infection and Vaccine Bo…

Cleveland Clinic Rheumatology and Immunology Series

L. Calabrese

6.4K views
01:58

The COVID-19 Global Rheumatology Alliance: Collecting Evidence-Based…

Covid-19 Global Rheumatology Alliance

P. Robinson, J. Yazdany

72 views
18:24

Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

127 views
14:51

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

ACR Convergence 2021 Coverage

S. Sattui Cortes

154 views
08:33

HCQ in Patients With Rheumatic Disease Complicated by COVID-19: Clar…

The Journal of Rheumatology

S. J. Balevic

97 views
15:27

Treatment of RMD COVID-19 Patients: Are Anti-Rheumatic Drugs Proving…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

L. Wise

376 views
07:43

Cleveland Clinic ACR 2020 Updates on COVID-19: Has Tocilizumab Prove…

Cleveland Clinic Rheumatology and Immunology Series

L. Calabrese

1.0K views
18:35

COVID-19 in RMD Patients: What Are the Risk Factors for Severe COVID…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

L. Wise

670 views
29:06

Vaccines for IMIDS: State of the Art

Cleveland Clinic Department of Rheumatic and Immunologic Disease

C. Calabrese

306 views
51:16

COVID-19 and Rheumatic Diseases

Yale School of Medicine

V. Chowdhary

144 views
24:32

Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of Labs …

RheumNow

J. Cush, R. Tate, Y. Yusof, B. Mehta, O. Petryna

200 views
19:39

Principles of Managing COVID-19 in High Risk Outpatients

Cleveland Clinic Department of Rheumatic and Immunologic Disease

C. Calabrese

136 views
22:24

JAK Inhibitors in the COVID-19 Era: Assessing the Risks and Benefit

Cleveland Clinic Department of Rheumatic and Immunologic Disease

K. Winthrop

103 views
05:35

Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection…

The Journal of Rheumatology

J. Curtis

85 views
22:39

The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment

The Journal of Rheumatology

E. Silverman, J. Rosenbaum, J. Reveille, K. Winthrop

65 views
20:38

COVID-19 and the Risks From Immunomodulatory Therapies

Cleveland Clinic Department of Rheumatic and Immunologic Disease

Z. Wallace

63 views
10:00

RheumNow Updates on Pemphigus Vulgaris, the Efficacy of JAK Inhibito…

RheumNow

J. Cush

61 views
05:29

Rheumatic Disease Patients with COVID-19: Is Timing Important for Bi…

RheumNow

J. Cush

55 views
26:25

Hyperinflammation and Immunomodulatory Drugs Trials in COVID-19

Cleveland Clinic Rheumatology

P. Mehta

48 views
14:08

Managing COVID-19 in Immune-Mediated Inflammatory Disease Patients: …

Cleveland Clinic Department of Rheumatic and Immunologic Disease

C. Calabrese, L. Calabrese, P. Mehta

36 views
AUTOPLAY